Progesterone 25 MG subcutaneous: Clinical Trials

1 trial of Progesterone 25 MG subcutaneous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Progesterone 25 MG subcutaneous: new trials by email Literature Review of Progesterone 25 MG subcutaneous trials Research Report on Progesterone 25 MG subcutaneous

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
Progesterone 25 MG subcutaneous, Micronized progesterone 200 MG, recombinant FSH - Infertility, In Vitro Fertilization
Phase 4TerminatedAndros Day Surgery Clinic602016-12-202020-01-10

Conditions studied

Infertility (1)

Sponsors

Andros Day Surgery Clinic (1)

Countries

Italy (1)

Top investigators

Adolfo Allegra, MD (1)